Analyst Ranking
Bottom 5%
#4714 out of 4939 analysts
Average Return
-8.29%
Win Rate
41%13 out of 32
Risk vs Reward
Poor
Good

Douglas Miehm's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Oncolytics Biotech IncONCY
+86.92%$0.64$1.20
2025-03-09 -
2025-07-14
Buy
Aurinia Pharmaceuticals IncAUPH
+59.81%$5.15$8.23
2022-11-03 -
2023-11-03
Buy
Ligand Pharmaceuticals IncLGND
+36.01%$93.32$126.92
2024-08-06 -
2025-07-14
Buy
Aurinia Pharmaceuticals IncAUPH
+33.16%$5.85$7.79
2024-02-15 -
2025-02-14
Buy
Bausch & Lomb CorpBLCO
+29.12%$15.35$19.82
2022-07-25 -
2023-07-25
Buy

Douglas Miehm Analyst Color

Get additional color on Douglas Miehm's coverage of popular stocks

Douglas Miehm's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Bausch Health Companies IncBHC
19Hold$10.00+57.73%Maintains
2 months ago
Bausch & Lomb CorpBLCO
13Buy$17.00+24.27%Maintains
3 months ago
Oncolytics Biotech IncONCY
1Buy$5.00+316.67%Maintains
4 months ago
Ligand Pharmaceuticals IncLGND
5Buy$143.00+12.67%Maintains
7 months ago
Aurinia Pharmaceuticals IncAUPH
8Buy$8.00N/AMaintains
a year ago
Crh Medical CorpCRHM
1HoldN/AN/ADowngrades
4 years ago
Novadaq Technologies IncNVDQ1
1HoldN/AN/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.